Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

77
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
77

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibulin-5 (FBLN5) as a context-dependent pan-cancer regulator: integrated multi-omics analysis reveals dual roles in tumor progression and therapeutic resistance.

Translational cancer research·2026
Same author

Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database.

PloS one·2026
Same author

Benign vs. malignant pulmonary nodules: pleural adhesion risks and predictors.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Integrating plasma proteomes with genome-wide association data for causal protein identification in hepatocellular carcinoma: A bidirectional Mendelian randomization study.

Medicine·2026
Same author

Systematic analysis of doxorubicin-induced myocardial injury mechanisms using network toxicology and molecular docking strategy.

Medicine·2025
Same author

Comparative effectiveness of surgery versus radiotherapy for non-nasopharyngeal head and neck lymphoepithelial carcinoma: An IPTW propensity score analysis.

PloS one·2025

Related Experiment Video

Updated: May 22, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

199

Survival advantage of radiotherapy and nomogram for patients with pulmonary neuroendocrine neoplasms: a propensity

Jingtao Tong1, Kaitai Liu1, Guodong Xu2

  • 1Department of Radiation Oncology and Chemotherapy, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.

Journal of Thoracic Disease
|March 14, 2025
PubMed
Summary
This summary is machine-generated.

Radiotherapy (RT) shows survival benefits for pulmonary neuroendocrine neoplasms (pNENs) patients, especially those not undergoing surgery. A new nomogram aids in predicting prognosis for this group.

Keywords:
Pulmonary neuroendocrine neoplasms (pNENs)nomogrampropensity score matching (PSM)radiation therapysurvival benefit

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

Related Experiment Videos

Last Updated: May 22, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

199
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K

Area of Science:

  • Oncology
  • Pulmonary Medicine
  • Radiotherapy

Background:

  • Standard treatment for pulmonary neuroendocrine neoplasms (pNENs) involves surgery for early stages.
  • Radiotherapy (RT) is an option for advanced or unresectable lung cancers.

Purpose of the Study:

  • To evaluate the prognostic value of RT in patients with pNENs.
  • To identify factors influencing survival in pNENs patients.

Main Methods:

  • Utilized Surveillance, Epidemiology, and End Results database (2000-2019).
  • Employed propensity score matching for RT and no-RT groups.
  • Conducted survival analyses (overall and cancer-specific) using Cox regression and developed a predictive nomogram.

Main Results:

  • 7,470 pNEN cases identified; 1,429 in the RT group were matched 1:1 with controls.
  • RT was not significantly associated with survival benefits in the surgery group.
  • RT demonstrated a survival benefit in the no-surgery group.
  • Age, sex, marital status, disease extension, surgery, and RT were independent prognostic factors.

Conclusions:

  • RT may improve survival for pNEN patients, particularly those not receiving surgery.
  • A developed nomogram accurately predicts prognosis for pNEN patients.